Prevalence and Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease

Abdominal Aortic Aneurysm Clinical Trial

— CAD-AAA  

Official title:

Prevalence and Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01897623
• Other study ID #: AAA-CAD-02
• Status: Completed
• Phase: N/A
• First received: July 9, 2013
• Last updated: December 15, 2014
• Start date: July 2013
• Est. completion date: October 2014

Study information

• Verified date: December 2014
• Source: North Karelia Central Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Finland: Ethics CommitteeFinland: Valvira - National Supervisory Authority for Welfare and Health
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to investigate the prevalence of abdominal aortic aneurysms (AAA) among male patients with coronary artery disease (CAD) verified in coronary angiography. Ethiology of AAA is known to be common with atherosclerotic arterial diseases (coronary artery disease, peripheral artery disease and carotid artery disease), so the hypothesis is that AAA should be more common among these CAD patients, thus making screening of these patients (for AAA) more cost-efficient.

Study will be carried out as a multi-center prospective screening study. Data will be collected in North Karelia Central Hospital, Kuopio University Hospital and Tampere University Hospital. Data consists of 200 consecutive coronary angiography patients in each hospital, resulting in 600 patients in total. All male patients with diagnosed CAD will be recruited for the study and screened for AAA with ultrasound. Nevertheless, patients with previously known AAA will be excluded from the study.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. completion date: October 2014
• Est. primary completion date: October 2014
• Gender: Male
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Male patients with coronary artery disease

Exclusion Criteria:

• Patient's denial to participate

• Female Gender

• Already diagnosed or treated abdominal aortic aneurysm

Study Design

Primary Purpose: Screening

Related Conditions & MeSH terms

• Abdominal Aortic Aneurysm
• Aneurysm
• Aortic Aneurysm
• Aortic Aneurysm, Abdominal
• Coronary Artery Disease
• Coronary Disease
• Myocardial Ischemia

Intervention

Other:
• ultrasound of aorta

Locations

Country	Name	City	State
Finland	North Carelia Central Hospital	Joensuu	Pohjois-Karjala

Sponsors (3)

Lead Sponsor	Collaborator
North Karelia Central Hospital	Kuopio University Hospital, Tampere University Hospital

Country where clinical trial is conducted

Finland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Maximum diameter (mm) of abdominal aorta (outer-to-outer wall) in ultrasound		upon screening	No